We recently developed a GFP-expressing strain of TPA that laid the groundwork for a flow cytometric assay to quantitate OM damage inflicted by ECL antibodies in IRS and ECL-specific antibodies elicited by immunization (11). This evidence concerns the gene PLAT and ocular melanoma.